← Back to Glossary
X

Xerostomia Management Strategy

Biopharmaceutical Glossary

Xerostomia management strategy addresses dry mouth from reduced saliva reducing palatability and increasing infections. Salivary substitute products restore moisture temporarily. Salivary gland stimulation through chewing enhances production. Pilocarpine activates muscarinic receptors increasing flow. Preventive strategies minimise gland exposure.

Clinical monitoring detects severity progression. Supportive care addresses comfort and infection prevention. Regulatory submissions address xerostomia risks. Patient counselling emphasises oral care. Post-approval surveillance identifies xerostomia patterns.

← Back to Glossary
WhatsApp WeChat